Hedge Fund - Parkman Healthcare Partners
Alnylam Pharmaceuticals Inc. (ALNY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $30,110,498 | 3.46% | 92,338 | $276.71 |
| 2 | 2025 - Q1 (2025-03-31) | $18,614,639 | 2.21% | 68,938 | $257.00 |
| 3 | 2024 - Q4 (2024-12-31) | $9,099,908 | 1.21% | 38,672 | $262.99 |
| 4 | 2024 - Q3 (2024-09-30) | $7,009,140 | 0.89% | 25,485 | $260.36 |
| 5 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $213.29 |
| 6 | 2022 - Q3 (2022-09-30) | $2,176,000 | 0.61% | 10,873 | $190.74 |
| 7 | 2022 - Q2 (2022-06-30) | $3,024,000 | 1.11% | 20,734 | $141.87 |
| 8 | 2022 - Q1 (2022-03-31) | $8,819,000 | 2.58% | 54,008 | $152.35 |
| 9 | 2021 - Q4 (2021-12-31) | $9,782,000 | 2.15% | 57,682 | $185.86 |
| 10 | 2021 - Q3 (2021-09-30) | $14,155,000 | 3.58% | 74,967 | $187.58 |
| 11 | 2021 - Q2 (2021-06-30) | $12,708,000 | 2.77% | 74,967 | $146.46 |
| 12 | 2021 - Q1 (2021-03-31) | $9,183,000 | 2.13% | 65,043 | $150.49 |
| 13 | 2020 - Q4 (2020-12-31) | $4,700,000 | 1.2% | 36,161 | $133.53 |
| 14 | 2020 - Q3 (2020-09-30) | $4,494,000 | 1.18% | 30,863 | $142.11 |
| 15 | 2020 - Q2 (2020-06-30) | $5,312,000 | 1.49% | 35,863 | $134.81 |
| 16 | 2020 - Q1 (2020-03-31) | $3,958,000 | 1.83% | 36,363 | $115.43 |
| 17 | 2019 - Q4 (2019-12-31) | $4,031,000 | 1.16% | 35,000 | $99.70 |
The displayed share prices are average quarterly stock market prices.